# FDA Approves Sandoz Generic Drug Application Sandoz has received FDA approval for ANDA212069, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceuticals sector. The approval strengthens Sandoz's ability to offer cost-effective therapeutic alternatives and could pressure pricing for branded competitors in the affected market segment.